Drug Price Medicaid Fraud Lawsuit Information and Inflated Drug Average Wholesale Price Fraud Whistleblower Lawsuit Information

Drug Price Medicaid Fraud Lawsuit Information, Inflated Average Wholesale Price Medicaid Fraud Lawsuit Information, Medicaid Fraudulent Drug Price Lawsuit Information, Drug Price Kickback Lawsuit Information, Pharmaceutical False Price Lawsuit, and Medicaid Drug Price Fraud Lawsuit Information by Texas Inflated Average Wholesale Price and Medicaid Drug Price Fraud Lawyer Jason S. Coomer 

On February 1, 2011, a Travis County, Texas jury found that a global pharmaceutical manufacturer had misrepresented drug prices to the state's Medicaid program and said the drug company should pay the state and federal government $170.3 million.  These Drug Price Medicaid Fraud Lawsuits are becoming more common as evidence is coming to light that the $700 Billion a year drug industry includes some large drug companies that are defrauding Medicaid, Medicare, the VA, Tricare, and other governmental benefit programs out of vasts amounts of money.

Several governmental officials have made it clear that those who defraud the Medicaid program, Medicare, the VA, Tricare, CHIP and other government benefit programs will be held accountable for their actions.  Recent changes in the False Claims Act and other Qui Tam laws have created stronger protections and economic incentives for whistleblowers with knowledge of drug price fraud and other forms of Medicare Fraud and Medicaid Fraud.  As such, it is important for drug price fraud whistleblowers, pharmaceutical representative whistleblowers, medical device sales representative whistleblowers, drug marketing representative whistleblowers, and other drug executive whistleblowers to blow the whistle on drug fraud pricing schemes.

Pharmaceutical Company Drug Price Fraud Whistleblower Lawsuit Information, Drug Company False Drug Pricing Whistleblower Lawsuit Information, Pharmaceutical Executive Whistleblower Lawsuit Information, Medicaid False Drug Price Lawsuit Information, and Medicare False Drug Pricing Lawsuit Information

Pharmaceutical Companies and Drug Companies that engage in schemes to report false and inflated prices for pharmaceutical products, knowing that federal healthcare programs rely on those reported prices to set payment rates are committing Drug Price Fraud and can be held liable for these illegal actions.  The difference between the resulting inflated government payments and the actual price paid by healthcare providers for a drug is referred to as the “spread.” The larger the spread on a drug, the larger the profit for the drug company, health care provider or pharmacist who is reimbursed by the government.  For this reason there is an economic incentive for drug companies to artificially inflate the spread or price as much as possible in order to make higher profits at the expense of taxpayers.

Pharmaceutical Executives that commit drug pricing fraud, cooperate with other drug executives that are committing drug price fraud, or fail to report fraudulent drug price schemes can be held liable for criminal and civil prosecution.  In fact, several pharmaceutical executives have been convicted of drug price fraud and have been sent to prison.  Further, the government is cracking done on drug price fraud schemes and is actively encouraging drug price fraud whistleblowers to step forward to report fraudulent drug pricing schemes that are costing government health care programs like Medicaid, Medicare, Tricare, and the Veteran's Administration millions of dollars.  Pharmaceutical Sales Executives, Pharmacists, Drug Representatives, and other health care professionals that properly blow the whistle on fraudulent drug pricing schemes can receive a significant recovery on money recovered by being the first to file on Drug Price Medicare fraud, Drug Price Medicaid fraud, Drug Price Tricare fraud, and/or Drug Price VA.

Drug Price Fraud Whistleblower Lawsuit Information, Inflated Average Wholesale Price Fraud Whistleblower Lawsuit Information, Medicare Fraudulent Drug Price Fraud Whistleblower Lawsuit Information, Drug Price Kickback Whistleblower Lawsuit Information, Pharmaceutical False Price Information Whistleblower Lawsuit, and Drug Representative Whistleblower Lawsuit Information 

Pharmaceutical executives and representatives who are the original source of specialized knowledge of drug pricing fraud can recover large economic rewards for properly reporting fraudulent drug pricing schemes.  A successful false claims act qui tam claim can not only result in a significant recovery for the drug representative whistleblower, pharmaceutical executive whistleblower, or pharmaceutical accounting whistleblower, but can result in uncovering Medicare price fraud, Medicaid price fraud, Tricare price fraud, and/or VA price fraud that could result in millions or billions of dollars being recovered or saved by taxpayers.

There are several keys to a successful Drug Price Fraud False Claims Act Qui Tam Whistleblower Lawsuit including 1) obtaining original and specialized information of the fraud, 2) being the first to file regarding the specific fraud, and 3) protecting the whistleblower for retaliation.  

Feel free to go to the following web page for Inflated Average Wholesale Price Whistleblower Lawsuit Information & Drug Price Fraud Lawsuit Information